Next Article in Journal
Verteporfin Inhibits Severe Fever with Thrombocytopenia Syndrome Virus Infection via Inducing the Degradation of the Viral Gn Protein
Previous Article in Journal
Development and Evaluation of Bilayer Sustained-Release Tablets of Ruxolitinib Using Discriminative Pharmacokinetic Analysis and IVIVC
 
 
Article

Article Versions Notes

Pharmaceutics 2025, 17(4), 433; https://doi.org/10.3390/pharmaceutics17040433
Action Date Notes Link
article xml file uploaded 28 March 2025 07:52 CET Original file -
article xml uploaded. 28 March 2025 07:52 CET Update -
article pdf uploaded. 28 March 2025 07:52 CET Version of Record https://www.mdpi.com/1999-4923/17/4/433/pdf-vor
article html file updated 28 March 2025 07:53 CET Original file -
article xml file uploaded 28 March 2025 09:43 CET Update -
article xml uploaded. 28 March 2025 09:43 CET Update -
article pdf uploaded. 28 March 2025 09:43 CET Updated version of record https://www.mdpi.com/1999-4923/17/4/433/pdf-vor
article html file updated 28 March 2025 09:45 CET Update -
article xml file uploaded 28 March 2025 09:52 CET Update -
article xml uploaded. 28 March 2025 09:52 CET Update -
article pdf uploaded. 28 March 2025 09:52 CET Updated version of record https://www.mdpi.com/1999-4923/17/4/433/pdf-vor
article html file updated 28 March 2025 09:53 CET Update -
article xml file uploaded 2 April 2025 04:36 CEST Update -
article xml uploaded. 2 April 2025 04:36 CEST Update https://www.mdpi.com/1999-4923/17/4/433/xml
article pdf uploaded. 2 April 2025 04:36 CEST Updated version of record https://www.mdpi.com/1999-4923/17/4/433/pdf
article html file updated 2 April 2025 04:37 CEST Update https://www.mdpi.com/1999-4923/17/4/433/html
Back to TopTop